Auransa, Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
  • Digital Health
    • Artificial Intelligence
  • Pharmaceuticals
See more in Biomedtracker

Latest on Auransa, Inc.

Scrip

Deal Watch: AbbVie To Try Caraway’s Lysosomal Function Approach To Parkinson’s

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17

Scrip

Coronavirus Update: Trump Tests Positive, US Pause Remains On AstraZeneca Vaccine

 
• By Scrip Team

Trump, First Lady Test Positive For Coronavirus Given the breaking news that both President Donald Trump and first lady Melania have both tested positive for the coronavirus, speculation is beginning

Scrip

Asia Deal Watch: Boost For Esperion's Cholesterol Candidate As Daiichi Brought On Board

 
• By Emily Hayes, Jung Won Shin, Ian Haydock, Anju Ghangurde, and Jo Shorthouse

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Esperion Hooks Daiichi Sanky